13 Stand Up To Cancer Innovative Grant Recipients
The projects funded all represent new approaches to the most important and challenging problems facing cancer researchers today. They address a wide range of cancer types and organ sites, including lung, ovarian and breast cancers, as well as leukemia and lymphomas. Some projects focus on developing improved therapies for difficult to treat cancers that affect children and young adults, including Ewing sarcoma and rhabdoid tumors. All the projects have the potential to significantly advance the identification of the complex mechanisms that cause cancers to occur and spread; to lead to the development of a new generation of targeted treatments; and to improve the methods of diagnosing cancers and monitoring the effects of treatment.
The 13 Stand Up To Cancer Innovative Research Grant recipients for 2009 are:
Fernando D. Camargo, Ph.D., Children's Hospital Boston: An Emerging Tumor Suppressor Pathway in Human Cancer
Elizabeth R. Lawlor, M.D., Ph.D., Childrens Hospital Los Angeles: Modeling Ewing Tumor Initiation in Human Neural Crest Stem Cells
Matthew Levy, Ph.D., Albert Einstein College of Medicine of Yeshiva University: Cancer Cell Specific, Self-delivering Pro-drugs
Markus Muschen, M.D., Childrens Hospital Los Angeles: Targeted Inhibition of BCL6 for Leukemia Stem Cell Eradication
William Pao, M.D., Ph.D., Vanderbilt-Ingram Cancer Center/Vanderbilt University: Identifying Solid Tumor Kinase Fusions via Exon Capture and 454 Sequencing
Charles M. Roberts, M.D., Ph.D., Dana-Farber Cancer Institute: Therapeutically Targeting the Epigenome in Aggressive Pediatric Cancers
|SOURCE Stand Up To Cancer|
Copyright©2009 PR Newswire.
All rights reserved